Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

BACKGROUND: In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates. OBJECTIVE OF STUDY: To observe the clinical eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemian, Seyed MohammadReza, Shafigh, Navid, Afzal, Golnaz, Jamaati, Hamidreza, Tabarsi, Payam, Marjani, Majid, Malekmohammad, Majid, Mortazavi, Seyed Mehdi, Khoundabi, Batoul, Mansouri, Davood, Moniri, Afshin, Hajifathali, Abbas, Roshandel, Elham, Mortaz, Esmaeil, Adcock, Ian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834188/
https://www.ncbi.nlm.nih.gov/pubmed/33358260
http://dx.doi.org/10.1016/j.pulmoe.2020.10.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834188/
https://www.ncbi.nlm.nih.gov/pubmed/33358260
http://dx.doi.org/10.1016/j.pulmoe.2020.10.017

Ejemplares similares